American International Group’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,892
Closed -$113K 2551
2024
Q1
$113K Sell
6,892
-59
-0.8% -$968 ﹤0.01% 2450
2023
Q4
$96.3K Sell
6,951
-29
-0.4% -$375 ﹤0.01% 2587
2023
Q3
$96.1K Buy
6,980
+249
+4% +$3.69K ﹤0.01% 2536
2023
Q2
$115K Buy
6,731
+331
+5% +$4.8K ﹤0.01% 2491
2023
Q1
$103K Buy
6,400
+127
+2% +$1.51K ﹤0.01% 2438
2022
Q4
$47.7K Buy
6,273
+42
+0.7% +$297 ﹤0.01% 2761
2022
Q3
$55K Buy
6,231
+89
+1% +$814 ﹤0.01% 2788
2022
Q2
$44K Buy
6,142
+286
+5% +$2.28K ﹤0.01% 2901
2022
Q1
$63K Sell
5,856
-606
-9% -$7.19K ﹤0.01% 2763
2021
Q4
$91K Buy
+6,462
New +$128K ﹤0.01% 2757

Other funds holding TYRA

American International Group's TYRA Position: Q2 2024 in Review

American International Group sold out of Tyra Biosciences (TYRA) in Q2 2024, closing a stake of 6,892 shares — an estimated $113K sold.

American International Group first reported a position in TYRA in Q4 2021 and held it in 10 quarters. The position peaked at $115K in Q2 2023. 79 funds tracked by Wall St. Rank hold TYRA as of Q2 2024.

  • American International Group reported no remaining Tyra Biosciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 6,892 Tyra Biosciences shares in Q2 2024, an estimated $113K.
  • American International Group first reported a position in Tyra Biosciences in Q4 2021 and held it in 10 quarters.
  • American International Group's Tyra Biosciences position peaked at $115K in Q2 2023.
  • 79 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.